IL6 and serum lipopolysaccharide activity: Since prostaglandins have been shown to affect the formation of pro-inflammatory cytokines, such as IL-6 [40], and IL-1β has been shown to induce mRNA expression of COX-2 [41], COX-inhibitors remain central to the treatment of the profound systemic inflammatory response associated with endotoxemia.